Dr. Mathias D. Lichterfeld

Dr. Lichterfeld is an infectious disease physician at BWH and an Associate Professor at HMS. He is also an Associate Member of the Ragon Institute and of the Broad Institute of MIT and Harvard. He received his medical degree from the University of Heidelberg, Germany and completed his residency at Massachusetts General Hospital. In 2008-2011, he was an infectious disease fellow at the Brigham and Women’s Hospital and at Massachusetts General Hospital, with Dr. Eric Rosenberg as his mentor. He is a member of the American Association for Clinical Investigation, a fellow of the Infectious Disease Society of America, and has served as a chartered member of several study sections at the National Institutes of Health.Dr. Lichterfeld’s research interests focus on retroviral infections, specifically on HIV-1. His laboratory explores how HIV-1 can persist in the human body for a lifetime, despite very effective antiretroviral therapy that is available now; these studies involve a platform of recently-developed new technologies for single-cell profiling of virally-infected cells. Dr. Lichterfeld also leads clinical trials in which novel therapeutic approaches for HIV eradication and cure are evaluated; several of these studies are currently enrolling new patients. In collaboration with investigators from the Harvard School of Public Health, Dr. Lichterfeld’s lab also participates as a co-investigator in clinical trials with HIV-1-infected infants from Botswana.

Dr. Lichterfeld is rated as an Experienced provider by MediFind in the treatment of Severe Acute Respiratory Syndrome (SARS). His top areas of expertise are HIV/AIDS, Sepsis, Severe Acute Respiratory Syndrome (SARS), and Hepatitis.

His clinical research consists of co-authoring 141 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Severe Acute Respiratory Syndrome (SARS).